| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000041243 |
| Receipt No. | R000047095 |
| Scientific Title | Development of anesthesia management robot that deeply learns signs of upper airway obstruction and diagnosis/procedure data of anesthesiologist |
| Date of disclosure of the study information | 2020/07/29 |
| Last modified on | 2021/01/28 (Ver. 2) |
| Basic information | ||
| Public title | Development of anesthesia management robot that deeply learns signs of upper airway obstruction and diagnosis/procedure data of anesthesiologist | |
| Acronym | Development of anesthesia management robot | |
| Scientific Title | Development of anesthesia management robot that deeply learns signs of upper airway obstruction and diagnosis/procedure data of anesthesiologist | |
| Scientific Title:Acronym | Development of anesthesia management robot | |
| Region |
|
|
| Condition | |||
| Condition | dentistry | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The main purpose of this study is to digitize quantifiable items from various physiological functions that regulate the respiratory function during sedation into large-scale data, and use AI (artificial intelligence) to determine the severity of anesthesiologist illness. It is to develop an anesthesia management robot equipped with a new AI respiration monitor by performing deep learning using the judgment of the degree and the treatment of airway maintenance as teacher data. |
| Basic objectives2 | Others |
| Basic objectives -Others | Sedation and non-intubation intravenous anesthesia have been applied in cases such as minor surgical operations/procedures, examinations, and dental treatments, but because they are managed under spontaneous breathing, there is always a risk of upper airway obstruction. is there. During sedation, respiratory management is performed by performing continuous measurements such as transcutaneous oxygen saturation, but the current condition is that no early signs of upper airway obstruction can be detected, and oxygen saturation is below 90%. After it began to decline, hypoxemia worsened suddenly, and in cases where the anesthesiologist was not involved in systemic management, it became a clinically extremely dangerous condition, such as delays in the airway maintenance of medical personnel. Could be. Therefore, it is necessary to detect the signs of upper airway obstruction early and generalize the diagnosis and treatment by anesthesiologists. |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Item 1: Waveform data of airflow limitation during inspiration and expiration obtained with a nasal mask
Item 2: Carbon dioxide data by capnograph with nasal cannula Item 3: Movement data of forehead, temporal region, chin, chest, and abdomen using an acceleration sensor Item 4: Percutaneous arterial oxygen saturation data Item 5: Depth of anesthesia data by BIS monitor and EMG activity Item 6 (Teacher data): Anesthesiologist's determination of upper airway obstruction during sedation and treatment data are created in advance by selective formation, and comments and correspondence are leveled. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Twenty adult healthy volunteers (volunteers) who agreed with the explanation of the content of the research plan are targeted. | |||
| Key exclusion criteria | 1)Patients with serious respiratory illness
2) Patients with serious cardiovascular disease 3)Diabetes patients with poor control 4)Severe renal disorder patient 5)Severe liver disorder patient 6)Patients who have hypersensitivity (allergy) to the drug to be used 7)Patients who are judged to be unsuitable by the research supervisor or the co-workers |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagasaki University | ||||||
| Division name | Dental Anesthesiology | ||||||
| Zip code | 8528588 | ||||||
| Address | Sakamoto Nagasaki Jpan | ||||||
| TEL | 81958197713 | ||||||
| ayuse@nagasaki-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagasaki University Hospital | ||||||
| Division name | Dental Anesthesiology | ||||||
| Zip code | 81958197713 | ||||||
| Address | Sakamoto Nagasaki Jpan | ||||||
| TEL | 81958197713 | ||||||
| Homepage URL | |||||||
| ayuse@nagasaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagasaki University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagasaki University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nagasaki university |
| Address | Sakamoto Nagasaki Jpan |
| Tel | 0958197714 |
| ayuse@nagasaki-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 長崎県 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | NONE |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047095 |